Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regional assignment of the human C1-inhibitor gene to 11q11-q13.1.

Literature DB >> 2323781

Regional assignment of the human C1-inhibitor gene to 11q11-q13.1.

A Theriault¹, K Whaley, A R McPhaden, E Boyd, J M Connor.

Abstract

In situ hybridisation using a biotinylated 1.8 kb human cDNA clone in both normal and structurally abnormal chromosomes supports regional localisation of the gene for human C1-inhibitor to chromosome 11q11-q13.1.

Entities: Gene Species

Mesh：

Substances：

Year: 1990 PMID： 2323781 DOI： 10.1007/bf00195824

Source DB: PubMed Journal: Hum Genet ISSN： 0340-6717 Impact factor: 4.132

4 in total

1. Chromosomal assignment of a glutamic acid transfer RNA (tRNAGlu) gene to 1p36.

Authors: E Boyd; A Theriault; J P Goddard; M Kalaitsidaki; D H Spathas; J M Connor
Journal: Hum Genet Date: 1989-01 Impact factor: 4.132

2. Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11.

Authors: A E Davis; A S Whitehead; R A Harrison; A Dauphinais; G A Bruns; M Cicardi; F S Rosen
Journal: Proc Natl Acad Sci U S A Date: 1986-05 Impact factor: 11.205

3. Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization.

Authors: S C Bock; K Skriver; E Nielsen; H C Thøgersen; B Wiman; V H Donaldson; R L Eddy; J Marrinan; E Radziejewska; R Huber
Journal: Biochemistry Date: 1986-07-29 Impact factor: 3.162

4. High-resolution in situ hybridization technique using biotinylated NMYC oncogene probe reveals periodic structure of HSRs in human neuroblastoma.

Authors: J A Garson; J A van den Berghe; J T Kemshead
Journal: Cytogenet Cell Genet Date: 1987

4 in total

8 in total

1. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors: Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal: J Allergy Clin Immunol Date: 2004-09 Impact factor: 10.793

Review 2. Complement biosynthesis by mononuclear phagocytes.

Authors: A R McPhaden; K Whaley
Journal: Immunol Res Date: 1993 Impact factor: 2.829

Review 3. Angioedema. Pathogenesis, differential diagnosis, and treatment.

Authors: Evangelo Frigas; Ugochukwu C Nzeako
Journal: Clin Rev Allergy Immunol Date: 2002-10 Impact factor: 8.667

4. Ecallantide for the treatment of hereditary angiodema in adults.

Authors: Michael Lunn; Erin Banta
Journal: Clin Med Insights Cardiol Date: 2011-05-17

5. Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety.

Authors: Michael Lunn; Carah Santos; Timothy Craig
Journal: J Blood Med Date: 2010-08-24